Crosslinked collagen hydrogels as corneal implants: effects of sterically bulky vs. non-bulky carbodiimides as crosslinkers

Ji-Yun Ahn, Lucia Kuffova, Kimberly Merrett, Debbie Mitra, John Forrester, Fengfu Li, May Griffith

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

We have previously shown that recombinant human collagen can be crosslinked with N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide (EDC) to fabricate transparent hydrogels possessing the shape and dimensions of the human cornea. These corneal implants have been tested in a Phase I human clinical study. Although these hydrogels successfully promoted corneal tissue and nerve regeneration, the gelling kinetics were difficult to control during the manufacture of the implants. An alternative carbodiimide capable of producing hydrogels of similar characteristics as EDC in terms of strength and biocompatibility, but with a longer gelation time would be a desirable alternative. Here, we compared the crosslinking kinetics and properties of hydrogels crosslinked with a sterically bulky carbodiimide, N-cyclohexyl-N'-(2-morpholinethyl) carbodiimide metho-p-toluenesulfonate (CMC), with that of EDC. CMC crosslinking was possible at ambient temperature whereas the EDC reaction was too rapid to control and had to be carried out at low temperatures. The highest tensile strength obtained using optimized formulations were equivalent, although CMC crosslinked hydrogels were found to be stiffer. The collagenase resistance of CMC crosslinked hydrogels was superior to that of EDC crosslinked hydrogels while biocompatibility was similar. We are also able to substitute porcine collagen with recombinant human collagen and show that the in vivo performance of both resulting hydrogels as full-thickness corneal implants is comparable in a mouse model of an orthotopic corneal graft. In conclusion, CMC is a viable alternative to EDC as a crosslinker for collagen-based biomaterials for use as corneal implants, and potentially for use in other tissue engineering applications.
Original languageEnglish
Pages (from-to)7796–7805
Number of pages10
JournalActa Biomaterialia
Volume9
Issue number8
Early online date22 Apr 2013
DOIs
Publication statusPublished - Aug 2013

Fingerprint

Carbodiimides
Hydrogels
Collagen
Biocompatibility
Crosslinking
Nerve Regeneration
Kinetics
Temperature
Tensile Strength
Biocompatible Materials
Collagenases
Gelation
Tissue Engineering
Tissue engineering
Biomaterials
Grafts
Cornea
Tensile strength
Swine
Tissue

Keywords

  • collagen
  • crosslinking
  • carbodiimides
  • cornea
  • orthotropic corneal graft

Cite this

Crosslinked collagen hydrogels as corneal implants : effects of sterically bulky vs. non-bulky carbodiimides as crosslinkers. / Ahn, Ji-Yun; Kuffova, Lucia; Merrett, Kimberly; Mitra, Debbie; Forrester, John; Li, Fengfu; Griffith, May.

In: Acta Biomaterialia, Vol. 9, No. 8, 08.2013, p. 7796–7805.

Research output: Contribution to journalArticle

Ahn, Ji-Yun ; Kuffova, Lucia ; Merrett, Kimberly ; Mitra, Debbie ; Forrester, John ; Li, Fengfu ; Griffith, May. / Crosslinked collagen hydrogels as corneal implants : effects of sterically bulky vs. non-bulky carbodiimides as crosslinkers. In: Acta Biomaterialia. 2013 ; Vol. 9, No. 8. pp. 7796–7805.
@article{7b8f0e9de8294caf91378f0df7f2035e,
title = "Crosslinked collagen hydrogels as corneal implants: effects of sterically bulky vs. non-bulky carbodiimides as crosslinkers",
abstract = "We have previously shown that recombinant human collagen can be crosslinked with N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide (EDC) to fabricate transparent hydrogels possessing the shape and dimensions of the human cornea. These corneal implants have been tested in a Phase I human clinical study. Although these hydrogels successfully promoted corneal tissue and nerve regeneration, the gelling kinetics were difficult to control during the manufacture of the implants. An alternative carbodiimide capable of producing hydrogels of similar characteristics as EDC in terms of strength and biocompatibility, but with a longer gelation time would be a desirable alternative. Here, we compared the crosslinking kinetics and properties of hydrogels crosslinked with a sterically bulky carbodiimide, N-cyclohexyl-N'-(2-morpholinethyl) carbodiimide metho-p-toluenesulfonate (CMC), with that of EDC. CMC crosslinking was possible at ambient temperature whereas the EDC reaction was too rapid to control and had to be carried out at low temperatures. The highest tensile strength obtained using optimized formulations were equivalent, although CMC crosslinked hydrogels were found to be stiffer. The collagenase resistance of CMC crosslinked hydrogels was superior to that of EDC crosslinked hydrogels while biocompatibility was similar. We are also able to substitute porcine collagen with recombinant human collagen and show that the in vivo performance of both resulting hydrogels as full-thickness corneal implants is comparable in a mouse model of an orthotopic corneal graft. In conclusion, CMC is a viable alternative to EDC as a crosslinker for collagen-based biomaterials for use as corneal implants, and potentially for use in other tissue engineering applications.",
keywords = "collagen, crosslinking, carbodiimides, cornea, orthotropic corneal graft",
author = "Ji-Yun Ahn and Lucia Kuffova and Kimberly Merrett and Debbie Mitra and John Forrester and Fengfu Li and May Griffith",
year = "2013",
month = "8",
doi = "10.1016/j.actbio.2013.04.014",
language = "English",
volume = "9",
pages = "7796–7805",
journal = "Acta Biomaterialia",
issn = "1742-7061",
publisher = "Elsevier BV",
number = "8",

}

TY - JOUR

T1 - Crosslinked collagen hydrogels as corneal implants

T2 - effects of sterically bulky vs. non-bulky carbodiimides as crosslinkers

AU - Ahn, Ji-Yun

AU - Kuffova, Lucia

AU - Merrett, Kimberly

AU - Mitra, Debbie

AU - Forrester, John

AU - Li, Fengfu

AU - Griffith, May

PY - 2013/8

Y1 - 2013/8

N2 - We have previously shown that recombinant human collagen can be crosslinked with N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide (EDC) to fabricate transparent hydrogels possessing the shape and dimensions of the human cornea. These corneal implants have been tested in a Phase I human clinical study. Although these hydrogels successfully promoted corneal tissue and nerve regeneration, the gelling kinetics were difficult to control during the manufacture of the implants. An alternative carbodiimide capable of producing hydrogels of similar characteristics as EDC in terms of strength and biocompatibility, but with a longer gelation time would be a desirable alternative. Here, we compared the crosslinking kinetics and properties of hydrogels crosslinked with a sterically bulky carbodiimide, N-cyclohexyl-N'-(2-morpholinethyl) carbodiimide metho-p-toluenesulfonate (CMC), with that of EDC. CMC crosslinking was possible at ambient temperature whereas the EDC reaction was too rapid to control and had to be carried out at low temperatures. The highest tensile strength obtained using optimized formulations were equivalent, although CMC crosslinked hydrogels were found to be stiffer. The collagenase resistance of CMC crosslinked hydrogels was superior to that of EDC crosslinked hydrogels while biocompatibility was similar. We are also able to substitute porcine collagen with recombinant human collagen and show that the in vivo performance of both resulting hydrogels as full-thickness corneal implants is comparable in a mouse model of an orthotopic corneal graft. In conclusion, CMC is a viable alternative to EDC as a crosslinker for collagen-based biomaterials for use as corneal implants, and potentially for use in other tissue engineering applications.

AB - We have previously shown that recombinant human collagen can be crosslinked with N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide (EDC) to fabricate transparent hydrogels possessing the shape and dimensions of the human cornea. These corneal implants have been tested in a Phase I human clinical study. Although these hydrogels successfully promoted corneal tissue and nerve regeneration, the gelling kinetics were difficult to control during the manufacture of the implants. An alternative carbodiimide capable of producing hydrogels of similar characteristics as EDC in terms of strength and biocompatibility, but with a longer gelation time would be a desirable alternative. Here, we compared the crosslinking kinetics and properties of hydrogels crosslinked with a sterically bulky carbodiimide, N-cyclohexyl-N'-(2-morpholinethyl) carbodiimide metho-p-toluenesulfonate (CMC), with that of EDC. CMC crosslinking was possible at ambient temperature whereas the EDC reaction was too rapid to control and had to be carried out at low temperatures. The highest tensile strength obtained using optimized formulations were equivalent, although CMC crosslinked hydrogels were found to be stiffer. The collagenase resistance of CMC crosslinked hydrogels was superior to that of EDC crosslinked hydrogels while biocompatibility was similar. We are also able to substitute porcine collagen with recombinant human collagen and show that the in vivo performance of both resulting hydrogels as full-thickness corneal implants is comparable in a mouse model of an orthotopic corneal graft. In conclusion, CMC is a viable alternative to EDC as a crosslinker for collagen-based biomaterials for use as corneal implants, and potentially for use in other tissue engineering applications.

KW - collagen

KW - crosslinking

KW - carbodiimides

KW - cornea

KW - orthotropic corneal graft

U2 - 10.1016/j.actbio.2013.04.014

DO - 10.1016/j.actbio.2013.04.014

M3 - Article

VL - 9

SP - 7796

EP - 7805

JO - Acta Biomaterialia

JF - Acta Biomaterialia

SN - 1742-7061

IS - 8

ER -